Target intelligence / Profile preview

Rab-3A-interacting protein (RAB3IP)

Target
RAB3IP
Molecular classification
Guanyl-nucleotide exchange factor (GEF), Protein binding protein, Other (regulator of small GTPase signaling)
01

Overview

Rab-3A-interacting protein (RAB3IP) is a guanyl-nucleotide exchange factor (GEF) that promotes the exchange of GDP for GTP on Rab proteins, activating their signaling function[6]. It binds to Rab3A and related small GTPases, catalyzing their transition from an inactive GDP-bound state to an active GTP-bound state, thereby regulating membrane trafficking, vesicle transport, and protein-protein interactions in various cellular processes[1][4][6]. RAB3IP is widely expressed in human tissues, participates in signal transduction and vesicle dynamics, and is associated with cellular compartmentalization, particularly in cytoplasm and cilia[1][3][4]. The molecule is implicated in some human diseases, notably cancer and potentially neurodegenerative conditions, through its regulatory role in vesicle transport and protein trafficking[2][4]. No directly interacting drugs, mechanism-of-action for such agents, specific biomarkers, or safety concerns are robustly described in the provided results.

Other names
RAB3IPRABIN3RABIN8Rabin-3Rabin8SSX2-interacting proteinrabin3rab-3A-interacting proteinSSX2 interacting proteinFLJ22548
02

Biological functions

Guanyl-nucleotide exchange (GDP-GTP exchange for Rab proteins)Signal transductionProtein-protein interactionsVesicle trafficking
03

Disease associations

Cancer (including potential relevance in prostate cancer and neurodegeneration)Other (implicated in cellular trafficking and possibly ciliopathies, though specific links not robustly referenced in the results)

Beyond the preview

Go deeper on Rab-3A-interacting protein (RAB3IP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rab-3A-interacting protein (RAB3IP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call